Managers / Q1 2021 · view latest →
Planned Solutions, Inc.
CIK 0001831332 · 1130 IRON POINT ROAD, SUITE 170, FOLSOM, CA, 95630 · 9163610100
Summary
Planned Solutions, Inc. reported $128M in U.S.-listed holdings across 60 positions for Q1 2021.
Its largest position, Vaneck Vectors Morningstar Wide Moat Etf, represents 15.4% of the portfolio.
Compared with Q4 2020, the fund opened 0 new positions and exited 407.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 89.1% · $114M
- Common Stock · 10.5% · $13M
- REIT · 0.4% · $519,000
Quarter-over-Quarter Changes full breakdown →
vs Q4 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| VANGUARD FTSE ALL-WORLD EX US INDEX FUND | ADDED | +141.3K | 141.5K | +$9M | $9M |
| ISHARES TIPS BOND ETF | ADDED | +38.4K | 45.9K | +$5M | $6M |
| GSGOLDMAN SACHS GROUP INC COM | ADDED | +495 | 870 | +$185,000 | $284,000 |
| VANGUARD TOTAL BOND MARKET INDEX FUND | SOLD OUT | −2.4K | 0 | −$209,000 | $0 |
| ISHARES S&P SMALL-CAP FUND | SOLD OUT | −2.1K | 0 | −$192,000 | $0 |
| VANGUARD HEALTH CARE INDEX FUND | SOLD OUT | −858 | 0 | −$192,000 | $0 |
| TMOTHERMO FISHER SCIENTIFIC INC COM | SOLD OUT | −392 | 0 | −$183,000 | $0 |
| SRCUSDSPIRIT RLTY CAP INC NEW COM NEW | SOLD OUT | −4.4K | 0 | −$178,000 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2021
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $306M | 139 | Apr 9, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $312M | 139 | Jan 28, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $291M | 138 | Oct 23, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $263M | 123 | Jul 29, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $247M | 113 | Apr 9, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $248M | 111 | Jan 17, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $249M | 662 | Oct 9, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $207M | 103 | Jul 24, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $204M | 102 | Apr 26, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $166M | 80 | Feb 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $169M | 80 | Jul 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $158M | 78 | Apr 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $137M | 75 | Jan 25, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $120M | 64 | Oct 20, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $107M | 63 | Jul 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $143M | 71 | Apr 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $149M | 78 | Feb 3, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $145M | 68 | Jul 21, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $128M | 60 | Apr 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $125M | 467 | Jan 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $102M | 344 | Nov 6, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.